Access cutting-edge alcoholic liver disease treatment through this clinical trial at a research site in Indianapolis. Study-provided care at no cost to qualified participants.
Access alcoholic liver disease specialists in Indianapolis at no cost
This study follows strict safety protocols and ethical guidelines
All study-related alcoholic liver disease treatment provided free
The goal of this study is to assess the safety and efficacy of GSK4532990 in participants with alcohol-related liver disease.
Sponsor: GlaxoSmithKline
Check if you qualify for this alcoholic liver disease clinical trial in Indianapolis, IN
If you're searching for alcoholic liver disease treatment options in Indianapolis, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Indianapolis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced alcoholic liver disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.